Robert Pirker
Impact in
- Oncology top 0.1%
- Drug Transport and Resistance Mechanisms
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 132
- Lung Cancer Research Studies 51
- Drug Transport and Resistance Mechanisms 31
- Colorectal Cancer Treatments and Studies 25
-
- Lung Cancer Treatments and Mutations 120
- Lung Cancer Diagnosis and Treatment 57
- Co-authors
- Martin Filipits (70 shared papers)Thierry Le Chevalier (22 shared papers)Ariane Dunant (19 shared papers)Helmut Popper (23 shared papers)Jean‐Pierre Pignon (16 shared papers)Jean‐Charles Soria (20 shared papers)Élisabeth Brambilla (16 shared papers)Joachim von Pawel (14 shared papers)
- Journals
- Lung Cancer (30 papers)Journal of Clinical Oncology (26 papers)Annals of Oncology (17 papers)Journal of Thoracic Oncology (17 papers)European Journal of Cancer (10 papers)
- Partner nations
- AustriaUnited StatesFrance
In The Last Decade
Robert Pirker
239 papers receiving 11.4k citations
Robert Pirker's Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 5.9k
- Pulmonary and Respiratory Medicine 4.3k
- Cancer Research 1.3k
- Hematology 677
- Internal Medicine 181
Countries citing papers authored by Robert Pirker
This map shows the geographic impact of Robert Pirker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Pirker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Pirker more than expected).
Fields of papers citing papers by Robert Pirker
This network shows the impact of papers produced by Robert Pirker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Pirker. The network helps show where Robert Pirker may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Pirker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 251 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy Hit paper breakdown → | 2006 | 1323 |
| 2 | Expression of Multidrug Resistance Gene in Human Cancers Hit paper breakdown → | 1989 | 1083 |
| 3 | Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial Hit paper breakdown → | 2009 | 1051 |
| 4 | EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study Hit paper breakdown → | 2011 | 455 |
| 5 | 1991 | 309 | |
| 6 | 2009 | 296 | |
| 7 | Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non–Small-Cell Lung Cancer Hit paper breakdown → | 2016 | 275 |
| 8 | 2012 | 255 | |
| 9 | 2010 | 228 | |
| 10 | 2009 | 219 | |
| 11 | 2002 | 219 | |
| 12 | 2007 | 213 | |
| 13 | Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions Hit paper breakdown → | 2023 | 201 |
| 14 | 2012 | 142 | |
| 15 | 2008 | 130 | |
| 16 | 2000 | 128 | |
| 17 | 2012 | 118 | |
| 18 | 2017 | 97 | |
| 19 | 2013 | 96 | |
| 20 | 2007 | 95 |
About Robert Pirker
Robert Pirker is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 251 papers that have together received 11.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (120 papers), Lung Cancer Diagnosis and Treatment (57 papers), Lung Cancer Research Studies (51 papers), Drug Transport and Resistance Mechanisms (31 papers), Colorectal Cancer Treatments and Studies (25 papers), Erythropoietin and Anemia Treatment (19 papers), Cancer Genomics and Diagnostics (16 papers) and Cancer therapeutics and mechanisms (15 papers). The work is most often cited by research in Oncology (5.9k citations), Pulmonary and Respiratory Medicine (4.3k citations), Cancer Research (1.3k citations), Hematology (677 citations) and Internal Medicine (181 citations). Robert Pirker has collaborated with scholars based in Austria, United States and France. Frequent co-authors include Martin Filipits, Thierry Le Chevalier, Ariane Dunant, Helmut Popper, Jean‐Pierre Pignon, Jean‐Charles Soria, Élisabeth Brambilla, Joachim von Pawel, Rodryg Ramlau and Kenneth J. O’Byrne. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.